Healthy extracts to start with on Fullscript, the leader

LAS VEGAS, Aug. 3, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has announced the launch of its premier citrus-bergamot SuperFruit™ heart health supplement, BergaMet PRO+™, on, the nation’s leading nursing service, started an integrative medicine delivery platform.

The launch, which is expected to be complete in the third quarter, will make BergaMet PRO+ available to the more than 70,000 healthcare professionals and their more than 5 million patients on the Fullscript care platform. It follows the recent entry of Healthy Extracts’ natural formulations for brain health into the retail market through Natural Grocers stores across the country.

“Our launch on Fullscript dramatically expands our reach to physicians and their millions of patients across the country,” said Duke Pitts, President of Healthy Extracts. “Thousands of physicians trust Fullscript to provide the best nutritional health and wellness supplements on the market today, making this another strong endorsement of the clinically proven heart health benefits of our BergaMet PRO+.”

As a result of more than 17 published clinical studies, citrus bergamot has been shown to improve heart health, support the immune response and address metabolic syndrome. Citrus Bergamot by Healthy Extracts has also been clinically shown to naturally lower cholesterol by lowering LDL and raising HDL.

According to the CDC, nearly 94 million US adults ages 20 and older have high cholesterol, which puts them at risk for heart disease. An estimated 35 million statins are prescribed each year to lower cholesterol, but these drugs can have numerous negative side effects.

A peer-reviewed clinical study showed that the naturally derived bergamot polyphenolic fraction (BPF) found in Healthy Extracts’ Citrus Bergamot can significantly enhance the beneficial effects of rosuvastatin, one of the most commonly prescribed cardiometabolic risk reduction drugs.

Healthy Extracts is the exclusive US and Canadian supplier of the world’s most potent citrus bergamot superfruit. BergaMet PRO+ has 47% BPF Gold potency compared to its closest competitor with only 38% BPF.

PRO+ is organic, vegan-friendly, non-GMO, gluten-free, and manufactured and tested by certified US facilities.

Healthy Extracts’ full line of natural health formulations addresses the fast-growing, multi-billion dollar heart health supplement market, which ResearchAndMarkets expects to grow at a CAGR of 5.9% and reach $24.8 billion by 2027.

To learn more about Healthy Extracts’ full line of clinically backed, natural products for brain and heart health, go to or

About Fullscript
Fullscript is a powerful treatment platform for integrative medicine practitioners, providing access to personalized treatment planning, ongoing wellness education, and the best nutritional supplements and wellness products in healthcare. With over a decade of development and use by more than 70,000 healthcare professionals serving over 5 million patients, Fullscript offers the scale, technology and expertise to support the growth of integrative medicine and the delivery of quality care. Visit for more information.

About healthy extracts “Live Life Young Again”
Healthy Extracts Inc. is a platform for the development or acquisition of scientifically advanced, clinically proven, plant-based proprietary products in select high-growth categories within the multi-billion dollar nutraceutical market.

The Company’s subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical, natural health supplements for the heart and brain. This includes the only heart health supplement containing Citrus Bergamot SuperFruit™. This superfruit is known for having the highest quality and concentration of polyphenols and flavonoids, and with heart-healthy benefits backed by more than 17 clinical studies.

UBN KETONOMICS® proprietary formulations have been clinically shown to support brain health, including memory, cognition, focus and neuroenergy. UBN is pursuing intellectual property licensing opportunities to monetize its IP portfolio of multiple issued and pending patents.

For more information visit:, or

Forward-Looking Statements and Safe Harbor Notice

All statements contained in this press release, other than statements of historical fact, are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that contain forward-looking words such as “forecast,” “expect,” “possibility,” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the company’s Annual Report on Form 10-K filed with the SEC on April 1, 2022 and in future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all of these risk factors and other cautionary statements.

The Company cautions that statements and assumptions made in this press release constitute forward-looking statements and are not guarantees of future performance. Forward-looking statements are based on estimates and opinions of management at the time the statement is made. The information contained herein is only as of the date of this publication. The Company and its management assume no obligation to revise any of these statements after the date of this press release.

Food and Drug Administration Disclosure

The product and formulation featured in this press release may not be used by or sold to persons under the age of 12. This product should be used only as directed on the label. Consult a physician prior to use if you have a serious medical condition or are taking any prescription medication. Before using this and any other dietary supplement, a doctor should be consulted. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™

Company contact for healthy extracts
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
E-mail contact

Investor and media contact
Ronald Both or Justin Lumley
CMA Investor & Media Relations
Tel (949) 432-7566
E-mail contact

Media contact:
Tim Randall
Tel (949) 432-7572
E-mail contact

A photo accompanying this announcement is available at

Add a Comment

Your email address will not be published.